 NEW YORK, Nov. 13, 2020 GLOBE NEWSWIRE -- BeyondSpring Inc. the Company or BeyondSpring NASDAQ: BYSI, a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the Jefferies London Healthcare Conference on November 17th. Details are as follows: 